NCT03791489View on ClinicalTrials.gov

Multi-Treatment PNN Modulation for Chronic Rhinitis

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 1, 2018

Primary Completion Date

July 18, 2019

Study Completion Date

July 18, 2019

Conditions
Chronic Rhinitis
Interventions
DEVICE

ClariFix

The ClariFix™ device (K162608) is an FDA 510(k) cleared Class II cryosurgical tool indicated for the destruction of unwanted tissue during surgical procedures, including in adults with chronic rhinitis.

Trial Locations (3)

18017

Bethlehem ENT, Bethlehem

78624

Tracy Byerly, MD, Fredericksburg

94108

San Francisco Otolaryngology Medical Group, San Francisco

All Listed Sponsors
lead

Arrinex, Inc.

INDUSTRY

NCT03791489 - Multi-Treatment PNN Modulation for Chronic Rhinitis | Biotech Hunter | Biotech Hunter